Cargando…

Reovirus inhibits interferon production by sequestering IRF3 into viral factories

Upon viral infection, an arms-race between the cellular intrinsic innate immune system and viral replication is established. To win this race, viruses have established multiple strategies to inhibit the cellular response. Mammalian reovirus (MRV) constitutes a great model to study pathogenesis and l...

Descripción completa

Detalles Bibliográficos
Autores principales: Stanifer, Megan L., Kischnick, Christian, Rippert, Anja, Albrecht, Dorothee, Boulant, Steeve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589761/
https://www.ncbi.nlm.nih.gov/pubmed/28883463
http://dx.doi.org/10.1038/s41598-017-11469-6
_version_ 1783262399452676096
author Stanifer, Megan L.
Kischnick, Christian
Rippert, Anja
Albrecht, Dorothee
Boulant, Steeve
author_facet Stanifer, Megan L.
Kischnick, Christian
Rippert, Anja
Albrecht, Dorothee
Boulant, Steeve
author_sort Stanifer, Megan L.
collection PubMed
description Upon viral infection, an arms-race between the cellular intrinsic innate immune system and viral replication is established. To win this race, viruses have established multiple strategies to inhibit the cellular response. Mammalian reovirus (MRV) constitutes a great model to study pathogenesis and life cycle of dsRNA viruses. It replicates in the cytosol of infected cells by forming viral induced-replication compartments, or viral factories. Little is known about the strategy used by MRV to evade the cellular intrinsic immune system. In this study, we unraveled that MRV induces a replication-dependent global reduction in interferon-mediated antiviral immune response. We determined that although MRV leads to the activation and phosphorylation of interferon regulatory factor 3 (IRF3), the nuclear translocation of IRF3 was impaired in infected cells. Additionally, we showed that MRV does not degrade IRF3 but sequesters it in cytoplasmic viral factories. We demonstrate that the viral factory matrix protein μNS is solely responsible for the sequestration of IRF3. This finding highlights novel mechanisms used by MRV to interfere with the intrinsic immune system and places the viral factories as not only a replication compartment but as an active strategy participating in immune evasion.
format Online
Article
Text
id pubmed-5589761
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55897612017-09-13 Reovirus inhibits interferon production by sequestering IRF3 into viral factories Stanifer, Megan L. Kischnick, Christian Rippert, Anja Albrecht, Dorothee Boulant, Steeve Sci Rep Article Upon viral infection, an arms-race between the cellular intrinsic innate immune system and viral replication is established. To win this race, viruses have established multiple strategies to inhibit the cellular response. Mammalian reovirus (MRV) constitutes a great model to study pathogenesis and life cycle of dsRNA viruses. It replicates in the cytosol of infected cells by forming viral induced-replication compartments, or viral factories. Little is known about the strategy used by MRV to evade the cellular intrinsic immune system. In this study, we unraveled that MRV induces a replication-dependent global reduction in interferon-mediated antiviral immune response. We determined that although MRV leads to the activation and phosphorylation of interferon regulatory factor 3 (IRF3), the nuclear translocation of IRF3 was impaired in infected cells. Additionally, we showed that MRV does not degrade IRF3 but sequesters it in cytoplasmic viral factories. We demonstrate that the viral factory matrix protein μNS is solely responsible for the sequestration of IRF3. This finding highlights novel mechanisms used by MRV to interfere with the intrinsic immune system and places the viral factories as not only a replication compartment but as an active strategy participating in immune evasion. Nature Publishing Group UK 2017-09-07 /pmc/articles/PMC5589761/ /pubmed/28883463 http://dx.doi.org/10.1038/s41598-017-11469-6 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Stanifer, Megan L.
Kischnick, Christian
Rippert, Anja
Albrecht, Dorothee
Boulant, Steeve
Reovirus inhibits interferon production by sequestering IRF3 into viral factories
title Reovirus inhibits interferon production by sequestering IRF3 into viral factories
title_full Reovirus inhibits interferon production by sequestering IRF3 into viral factories
title_fullStr Reovirus inhibits interferon production by sequestering IRF3 into viral factories
title_full_unstemmed Reovirus inhibits interferon production by sequestering IRF3 into viral factories
title_short Reovirus inhibits interferon production by sequestering IRF3 into viral factories
title_sort reovirus inhibits interferon production by sequestering irf3 into viral factories
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589761/
https://www.ncbi.nlm.nih.gov/pubmed/28883463
http://dx.doi.org/10.1038/s41598-017-11469-6
work_keys_str_mv AT stanifermeganl reovirusinhibitsinterferonproductionbysequesteringirf3intoviralfactories
AT kischnickchristian reovirusinhibitsinterferonproductionbysequesteringirf3intoviralfactories
AT rippertanja reovirusinhibitsinterferonproductionbysequesteringirf3intoviralfactories
AT albrechtdorothee reovirusinhibitsinterferonproductionbysequesteringirf3intoviralfactories
AT boulantsteeve reovirusinhibitsinterferonproductionbysequesteringirf3intoviralfactories